Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Raja Arul GL"'
Autor:
LaRue-Nolan KC; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, U.S.A., Raja Arul GL; Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden., Sigafoos AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Shi J; Department of Pathology and Clinical Labs, Rogel Cancer Center and Center for RNA Biomedicine, University of Michigan, Ann Arbor, MI, U.S.A., Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A.
Publikováno v:
The Biochemical journal [Biochem J] 2024 Aug 07; Vol. 481 (15), pp. 983-997.
Autor:
Sigafoos AN; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Tolosa EJ; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Carr RM; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Fernandez-Barrena MG; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Almada LL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Pease DR; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Hogenson TL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Raja Arul GL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Mousavi F; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.; Department of Oncology, University of Western Ontario, London, Canada., Sen S; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Vera RE; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Marks DL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Flores LF; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., LaRue-Nolan KC; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Wu C; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Bamlet WR; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Vrabel AM; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Sicotte H; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Schenk EL; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Smyrk TC; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Zhang L; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Rabe KG; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Oberg AL; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Zaphiropoulos PG; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden., Chevet E; Université de Rennes, CEDEX, Rennes, France., Graham RP; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Hagen CE; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., di Magliano MP; Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, Michigan., Elsawa SF; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, New Hampshire., Pin CL; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.; Department of Oncology, University of Western Ontario, London, Canada., Mao J; University of Massachusetts Medical School, Worcester, Massachusetts., McWilliams RR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Fernandez-Zapico ME; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1677-1689.
Autor:
Paradise BD; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, U.S.A., Gainullin VG; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A., Almada LL; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A., Sigafoos AN; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A., Sen S; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A., Vera RE; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A., Raja Arul GL; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, U.S.A., Toruner M; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A., Pease DR; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, U.S.A., Gonzalez AL; Facultad de Ciencias Exactas y Naturales, Instituto de Ciencias de la Tierra y Ambientales de La Pampa (INCITAP), Universidad Nacional de La Pampa - Consejo Nacional de Investigaciones Científicas y Técnicas (UNLPam-CONICET), La Pampa 6300, Argentina., Mentucci FM; Department of Pharmacy, University of Salerno, Salerno 84084, Italy., Grasso DH; Instituto de Estudios de la Inmunidad Humoral (IDEHU), Escuela de Farmacia y Bioquimica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires 1113, Argentina., Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A.
Publikováno v:
The Biochemical journal [Biochem J] 2023 Aug 16; Vol. 480 (15), pp. 1199-1216.
GLI1, a novel target of the ER stress regulator p97/VCP, promotes ATF6f-mediated activation of XBP1.
Autor:
Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Barroso K; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA; INSERM U1242, 'Oncogenesis, Stress, Signaling', Université de Rennes, Rennes, France; Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France., Sen S; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Toruner M; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Sigafoos AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Raja Arul GL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Pease DR; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Vera RE; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Olson RLO; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA., Auner HW; Imperial College London, London, UK., Pedeux R; INSERM U1242, 'Oncogenesis, Stress, Signaling', Université de Rennes, Rennes, France; Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France., Iovanna JL; Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France., Chevet E; INSERM U1242, 'Oncogenesis, Stress, Signaling', Université de Rennes, Rennes, France; Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France. Electronic address: eric.chevet@inserm.fr., Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA. Electronic address: fernandezzapico.martin@mayo.edu.
Publikováno v:
Biochimica et biophysica acta. Gene regulatory mechanisms [Biochim Biophys Acta Gene Regul Mech] 2023 Jun; Vol. 1866 (2), pp. 194924. Date of Electronic Publication: 2023 Feb 25.
Autor:
Raja Arul GL; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN, USA., Toruner MD; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN, USA., Gatenby RA; Department of Integrated Mathematical Oncology, Moffitt Cancer Center, Tampa, FL, USA., Carr RM; Department of Oncology, Mayo Clinic, Rochester, MN, USA. Electronic address: carr.ryan@mayo.edu.
Publikováno v:
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] [Pancreatology] 2022 Sep; Vol. 22 (6), pp. 730-740. Date of Electronic Publication: 2022 Jul 06.
Autor:
Raja Arul GL; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN, USA.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, USA., Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN, USA.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2021 Jul 07; Vol. 13 (7), pp. e14362. Date of Electronic Publication: 2021 May 31.